Anthracycline-based therapy of de novo acute myeloid leukemia in adults: Failure of first-cyde cytoreduction to predict second-cycle outcome

A scoring system to predict the risk of

A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia

✍ David Valcárcel; Pau Montesinos; Isabel Sánchez-Ortega; Salut Brunet; Jordi Este 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 2 views

## Abstract ## BACKGROUND: A prognostic index to predict induction death in adult patients receiving induction chemotherapy for de novo acute myeloid leukemia (AML) was developed. ## METHODS: The authors analyzed 570 patients (aged 16‐70 years) included in 2 multicenter trials of the CETLAM Grou